Description and Action: The Mycobacteriaceae have been known for many years to have antitumour activity. Immunocidin® Equine is an emulsion of mycobacterial cell wall fractions that have been modified to reduce their toxic and allergic effects, but retain their antitumour activity. Immunocidin® Equine stimulates the activation of macrophages and thymic lymphocytes which kill tumour cells.

Indications: Immunocidin® Equine is recommended for the immunotherapy of sarcoid tumours in horses. Although Immunocidin® Equine is administered by intratumoural injection, the response is generalized, and untreated sites frequently undergo regression. Remissions cannot be guaranteed as each tumour will vary in its response.

• Immunocidin® Equine is a CFIA-approved immunotherapeutic for the treatment of sarcoid tumors in horses. It has a high post-treatment tumor-free rate and is well tolerated by horses, including older animals.
• Immunocidin® Equine has minimal side effects and an excellent safety profile, safe for use in pregnant mares.
• Immunocidin® Equine is an emulsion of mycobacterial cell wall fractions that have been modified to reduce their toxic and allergic effect but retain their antitumour activity.
• Immunocidin® Equine stimulates the activation of macrophages and thymic lyphocytes which kill tumor cells.